Automation index

How much of a Biomedical engineer’s job can AI already do?

A protocol and a model come earlier. Kit that does not fail in theatre does not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

25%

AI can already do 25% of this job.

#230 / 633

Biomedical engineer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Design, validate and document clinical devices and software. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Tests, MDR and risk. Estimate No public source provides a precise figure. This is our estimate.	16%	32%	+5.1
Hospital, clinicians and maintenance. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Vendors, quality and traceability. Estimate No public source provides a precise figure. This is our estimate.	16%	18%	+2.9
User training and post-market watch. Estimate No public source provides a precise figure. This is our estimate.	18%	16%	+2.9
Not putting a half-built prototype in theatre. Estimate No public source provides a precise figure. This is our estimate.	16%	14%	+2.2
Total	100%		25%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

28%

#102 / 633

Industrial engineer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Model processes, balances and a first plant layout. Estimate No public source provides a precise figure. This is our estimate.	22%	45%	+9.9
Draft procedures, PFDs and operating instructions. Estimate No public source provides a precise figure. This is our estimate.	18%	40%	+7.2
Analyse cost, bottlenecks and OEE from data. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Coordinate suppliers, maintenance and production. Estimate No public source provides a precise figure. This is our estimate.	16%	18%	+2.9
Commissioning and plant trials. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Capex calls and industrial-safety liability. Estimate No public source provides a precise figure. This is our estimate.	12%	10%	+1.2
Total	100%		28%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low